Bergenbio ASA (BGBIO) - Cash Flow Conversion Efficiency

Latest as of December 2024: -1.249x

Based on the latest financial reports, Bergenbio ASA (BGBIO) has a cash flow conversion efficiency ratio of -1.249x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-153.24 Million ≈ $-16.13 Million USD) by net assets (Nkr122.70 Million ≈ $12.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Bergenbio ASA for the company's overall valuation and market capitalisation.

Bergenbio ASA - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Bergenbio ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bergenbio ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bergenbio ASA ranked by their cash flow conversion efficiency. See Bergenbio ASA cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Global Interactive Technologies, Inc NASDAQ:GITS	-0.134x
KWESST MICRO SYS.INC. F:62UA	-0.430x
Turbon AG F:TUR	0.056x
Lykos Metals Ltd AU:LYK	-0.312x
Charan Insurance Public Company Limited BK:CHARAN	0.003x
Conneqt Health Limited AU:CQT	1.844x
T3 Defense Inc. NASDAQ:DFNS	-0.031x
Paras Petrofils Limited NSE:PARASPETRO	N/A

Annual Cash Flow Conversion Efficiency for Bergenbio ASA (2014–2024)

The table below shows the annual cash flow conversion efficiency of Bergenbio ASA from 2014 to 2024. View Bergenbio ASA (BGBIO) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Nkr122.70 Million ≈ $12.91 Million	Nkr-153.24 Million ≈ $-16.13 Million	-1.249x	+43.24%
2023-12-31	Nkr127.48 Million ≈ $13.41 Million	Nkr-280.50 Million ≈ $-29.52 Million	-2.200x	+32.44%
2022-12-31	Nkr88.50 Million ≈ $9.31 Million	Nkr-288.23 Million ≈ $-30.33 Million	-3.257x	-312.75%
2021-12-31	Nkr384.43 Million ≈ $40.45 Million	Nkr-303.34 Million ≈ $-31.92 Million	-0.789x	-125.73%
2020-12-31	Nkr670.23 Million ≈ $70.53 Million	Nkr-234.29 Million ≈ $-24.65 Million	-0.350x	+58.28%
2019-12-31	Nkr219.75 Million ≈ $23.12 Million	Nkr-184.15 Million ≈ $-19.38 Million	-0.838x	-51.38%
2018-12-31	Nkr337.28 Million ≈ $35.49 Million	Nkr-186.71 Million ≈ $-19.65 Million	-0.554x	-15.37%
2017-12-31	Nkr350.35 Million ≈ $36.87 Million	Nkr-168.11 Million ≈ $-17.69 Million	-0.480x	+40.84%
2016-12-31	Nkr153.27 Million ≈ $16.13 Million	Nkr-124.31 Million ≈ $-13.08 Million	-0.811x	+16.51%
2015-12-31	Nkr64.75 Million ≈ $6.81 Million	Nkr-62.90 Million ≈ $-6.62 Million	-0.972x	-155.71%
2014-12-31	Nkr141.38 Million ≈ $14.88 Million	Nkr-53.72 Million ≈ $-5.65 Million	-0.380x	--

About Bergenbio ASA

OL:BGBIO Norway Biotechnology

Market Cap

$7.75 Million

Nkr73.62 Million NOK

Market Cap Rank

#27777 Global

#252 in Norway

Share Price

Nkr0.47

Change (1 day)

-5.91%

52-Week Range

Nkr0.47 - Nkr1.24

All Time High

Nkr4414.96